(0.58%) 5 076.00 points
(0.39%) 38 216 points
(0.76%) 17 572 points
(0.84%) $79.66
(2.38%) $1.978
(0.38%) $2 319.80
(-0.05%) $26.74
(1.56%) $969.80
(0.01%) $0.933
(0.18%) $11.05
(-0.05%) $0.798
(-1.05%) $92.28
1.34% £ 984.00
Live Chart Being Loaded With Signals
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe...
Stats | |
---|---|
Dzisiejszy wolumen | 4 022.00 |
Średni wolumen | 71 459.00 |
Kapitalizacja rynkowa | 328.83M |
EPS | £0 ( 2023-11-08 ) |
Następna data zysków | ( £0 ) 2024-06-13 |
Last Dividend | £0.200 ( 2001-07-04 ) |
Next Dividend | £0 ( N/A ) |
P/E | -4.28 |
ATR14 | £4.41 (0.45%) |
Wolumen Korelacja
Biotech Growth Trust PLC Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
AFRN.L | 0.952 |
LXI.L | 0.928 |
LOK.L | 0.925 |
VMUK.L | 0.919 |
ALFA.L | 0.917 |
JMI.L | 0.917 |
BNKS.L | 0.916 |
UTL.L | 0.916 |
SDIP.L | 0.914 |
NOG.L | 0.911 |
10 Najbardziej negatywne korelacje | |
---|---|
GLB.L | -0.947 |
UD04.L | -0.925 |
AMC.L | -0.918 |
UAI.L | -0.917 |
7DIG.L | -0.916 |
INX.L | -0.912 |
FCCN.L | -0.907 |
BVIC.L | -0.905 |
UNG.L | -0.905 |
TFG.L | -0.903 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Biotech Growth Trust PLC Korelacja - Waluta/Towar
Biotech Growth Trust PLC Finanse
Annual | 2022 |
Przychody: | £-37.65M |
Zysk brutto: | £-37.65M (100.00 %) |
EPS: | £-1.030 |
FY | 2022 |
Przychody: | £-37.65M |
Zysk brutto: | £-37.65M (100.00 %) |
EPS: | £-1.030 |
FY | 2022 |
Przychody: | £-209.71M |
Zysk brutto: | £-209.71M (100.00 %) |
EPS: | £-4.88 |
FY | 2021 |
Przychody: | £222.06M |
Zysk brutto: | £0.00 (0.00 %) |
EPS: | £4.44 |
Financial Reports:
No articles found.
Biotech Growth Trust PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £0.600 | 1998-07-13 |
Last Dividend | £0.200 | 2001-07-04 |
Next Dividend | £0 | N/A |
Payout Date | 2001-07-30 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | £1.200 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.26 | -- |
Div. Sustainability Score | 2.02 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.0835 | -- |
Year | Amount | Yield |
---|---|---|
1998 | £0.600 | 0.62% |
1999 | £0.400 | 0.57% |
2000 | £0 | 0.00% |
2001 | £0.200 | 0.10% |
2002 | £0 | 0.00% |
2003 | £0 | 0.00% |
2004 | £0 | 0.00% |
2005 | £0 | 0.00% |
2006 | £0 | 0.00% |
2007 | £0 | 0.00% |
2008 | £0 | 0.00% |
2009 | £0 | 0.00% |
2010 | £0 | 0.00% |
2011 | £0 | 0.00% |
2012 | £0 | 0.00% |
2013 | £0 | 0.00% |
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £0 | 0.00% |
2019 | £0 | 0.00% |
2020 | £0 | 0.00% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
VCAP.L | Dividend Knight | 2023-09-14 | Semi-Annually | 4 | 3.56% | |
MRCH.L | Dividend King | 2023-07-06 | Quarterly | 53 | 3.07% | |
DLN.L | Dividend Knight | 2023-09-07 | Semi-Annually | 32 | 1.77% | |
SHG.L | Dividend Knight | 2023-11-02 | Semi-Annually | 4 | 0.91% | |
IHP.L | Dividend Knight | 2023-06-08 | Semi-Annually | 7 | 1.08% | |
BOCH.L | Dividend Junior | 2023-05-04 | Insufficient data to determine frequency | 2 | 1.10% | |
OCN.L | Dividend Knight | 2023-05-18 | Annually | 19 | 3.96% | |
ESNT.L | Dividend King | 2023-09-21 | Semi-Annually | 20 | 4.44% | |
STAN.L | Dividend Knight | 2023-08-10 | Annually | 32 | 1.92% | |
JMAT.L | Dividend Knight | 2023-06-08 | Semi-Annually | 33 | 1.93% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 1.050 | 1.500 | 10.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.299 | 1.200 | -9.95 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.295 | 1.500 | -4.39 | -6.58 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.298 | 0.800 | -3.51 | -2.81 | [1 - 3] |
quickRatioTTM | 0.298 | 0.800 | -2.95 | -2.36 | [0.8 - 2.5] |
cashRatioTTM | 0.212 | 1.500 | 9.93 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0742 | -1.500 | 8.76 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -176.03 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.159 | 2.00 | -0.0530 | -0.106 | [0 - 30] |
freeCashFlowPerShareTTM | -0.159 | 2.00 | -0.0795 | -0.159 | [0 - 20] |
debtEquityRatioTTM | 0.0780 | -1.500 | 9.69 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 1.000 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 1.044 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.260 | 1.000 | -2.56 | -2.56 | [0.2 - 2] |
assetTurnoverTTM | -0.284 | 0.800 | -5.23 | -4.18 | [0.5 - 2] |
Total Score | 2.02 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -3.95 | 1.000 | -0.500 | 0 | [1 - 100] |
returnOnEquityTTM | -0.295 | 2.50 | -2.82 | -6.58 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.159 | 2.00 | -0.0530 | -0.159 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.159 | 2.00 | -0.0530 | -0.106 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -5.00 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0679 | 1.000 | -0.803 | 0 | [0.1 - 0.5] |
Total Score | -1.857 |
Biotech Growth Trust PLC
The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej